MedTrace Logo

Treatment of Malignant Strictures in Esophagus and Gastroesophageal Junction With Covered or Partially Covered Stent.

NCT02166320 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-01-05

No results posted yet for this study

Summary

Self expandable stent (SEMS) constitutes the main palliative treatment in advanced esophageal cancer. The palliative effect of SEMS is immediate when it comes to relief of dysphagia. The duration of this effect is however questionable. The design of SEMS can be of importance since the device can dislodge and as a consequence of that dysphagia recur. The hypothesis has therefore been formulated that a partially covered SEMS is associated with less tendency to dislocate as compared to those SEMS, recently developed, which are covered through their entire length.

Conditions

  • Esophageal Cancer
  • Cancer of Gastro Esophageal Junction
  • Palliative Treatment

Interventions

DEVICE

Partially covered SEMS

DEVICE

Fully covered SEMS

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    collaborator OTHER

  • Blekinge County Council Hospital

    collaborator OTHER

  • Danderyd Hospital

    collaborator OTHER

  • Karolinska University Hospital

    lead OTHER

Principal Investigators

  • Erik Johnsson, MdPhd · Sahlgrenska University Hospital, Clinic of Surgery

  • Magnus Nilsson, ass professor · Karolinska University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2015-01-31
Completion
2015-04-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02166320 on ClinicalTrials.gov